Preclinical Toxicology Studies | Charles River

vaccine & vector safety 

Charles River’s capabilities include vaccine and vector safety studies in multiple species. These studies provide not only efficacy and safety testing data for your vaccines and other anti-infective agents, but also support your pharmacologic/toxicologic evaluation of gene therapy constructs. We design and perform studies in CDC-approved quarantine facilities with BSL-2 ratings to fulfill your preclinical regulatory needs in a GLP-compliant environment.

Experience

  • Viral, parasitic, and bacterial vaccines
  • Both subunit and live vaccines
  • Various small molecule anti-infectious agents and immune enhancers
  • DNA and viral vectors
  • Multiple routes of vector/vaccine administration

 
Neurovirulence Safety Testing

Our scientists also offer neurovirulence safety testing, since many immunogenic attenuated vaccines are known to possess residual neurovirulence following introduction to the brain. Using direct intracerebral or intrathalamic injection, we conduct these studies to assess the safety of new vaccines and to evaluate the continued safety of established vaccine seed stocks following directed modification or changes in the manufacturing process.

Testing Design Features

  • Intracerebral or intrathalamic dosing
  • Clinical pathology analyses
  • Viral titer and antiviral antibody analyses
  • Anatomical pathology evaluation
  • Vector biodistribution by quantitative PCR


Additional information about our Vaccine and Vector Safety Testing capabilities is available in The SourceSM, o
ur new online scientific and educational information center. To register for The SourceSM, please click here. If you are already a member, click here to login.

If you have any questions, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 17-juin 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th Europea...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Seri...
view all
RMS Specialist Montreal, Canada

Charles River Laboratories, Inc.